|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/28/17 Bank of New York Mellon Corp 10-K 12/31/16 172:44M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 280K
3: EX-13.1 All Portions of 2016 Annual Report to Shareholders HTML 3.83M
5: EX-21.1 Primary Subsidiaries of the Company HTML 60K
6: EX-23.1 Consent of Kpmg LLP HTML 53K
7: EX-24.1 Power of Attorney HTML 58K
2: EX-12.1 Computation of Ratio of Earnings to Combined Fixed HTML 72K
Charges and Preferred Stock D
4: EX-18.1 Preferability Letter From Kpmg LLP for Change in HTML 50K
Accounting Principle
8: EX-31.1 Section 302 CEO Certification HTML 55K
9: EX-31.2 Section 302 CFO Certification HTML 55K
10: EX-32.1 Section 906 CEO Certification HTML 49K
11: EX-32.2 Section 906 CFO Certification HTML 49K
18: R1 Document and Entity Information HTML 77K
19: R2 Consolidated Income Statement HTML 190K
20: R3 Consolidated Income Statement (Unaudited) HTML 51K
(Parenthetical)
21: R4 Consolidated Comprehensive Income Statement HTML 103K
22: R5 Consolidated Comprehensive Income Statement HTML 51K
(Parenthetical)
23: R6 Consolidated Balance Sheet HTML 186K
24: R7 Consolidated Balance Sheet (Parenthetical) HTML 76K
25: R8 Consolidated Statement of Cash Flows HTML 201K
26: R9 Consolidated Statement of Changes in Equity HTML 129K
27: R10 Consolidated Statement of Changes in Equity HTML 54K
(Parenthetical)
28: R11 Summary of significant accounting and reporting HTML 146K
policies
29: R12 Acquisitions and dispositions HTML 59K
30: R13 Securities HTML 625K
31: R14 Loans and asset quality HTML 520K
32: R15 Goodwill and intangible assets HTML 177K
33: R16 Other assets HTML 99K
34: R17 Deposits HTML 53K
35: R18 Net interest revenue HTML 90K
36: R19 Noninterest Expense HTML 82K
37: R20 Income taxes HTML 140K
38: R21 Long-Term Debt HTML 109K
39: R22 Securitizations and variable interest entities HTML 112K
40: R23 Shareholders' equity HTML 108K
41: R24 Other comprehensive income (Loss) HTML 188K
42: R25 Stock-based compensation HTML 119K
43: R26 Employee benefit plans HTML 583K
44: R27 Company Financial Information HTML 178K
45: R28 Fair value measurement HTML 796K
46: R29 Fair value option HTML 82K
47: R30 Commitments and contingent liabilities HTML 133K
48: R31 Derivative instruments HTML 475K
49: R32 Lines of business HTML 177K
50: R33 International Operations HTML 114K
51: R34 Supplemental information to the Consolidated HTML 68K
Statement of Cash Flows
52: R35 Summary of significant accounting and reporting HTML 244K
policies (Policies)
53: R36 Summary of significant accounting and reporting HTML 59K
policies Summary of significant accounting and
reporting policies (Tables)
54: R37 Securities (Tables) HTML 621K
55: R38 Loans and asset quality (Tables) HTML 516K
56: R39 Goodwill and intangible assets (Tables) HTML 172K
57: R40 Other assets (Tables) HTML 94K
58: R41 Net interest revenue (Tables) HTML 90K
59: R42 Noninterest Expense (Tables) HTML 82K
60: R43 Income Taxes (Tables) HTML 142K
61: R44 Long-Term Debt (Tables) HTML 109K
62: R45 Securitizations and variable interest entities HTML 115K
(Tables)
63: R46 Shareholders' equity (Tables) HTML 160K
64: R47 Other comprehensive income (Loss) (Tables) HTML 185K
65: R48 Stock-based compensation (Tables) HTML 106K
66: R49 Employee benefit plans (Tables) HTML 573K
67: R50 Company Financial Information (Tables) HTML 165K
68: R51 Fair value measurement (Tables) HTML 771K
69: R52 Fair value option (Tables) HTML 82K
70: R53 Commitments and contingent liabilities (Tables) HTML 97K
71: R54 Derivative instruments (Tables) HTML 462K
72: R55 Lines of business (Tables) HTML 152K
73: R56 International Operations (Tables) HTML 113K
74: R57 Supplemental information to the Consolidated HTML 66K
Statement of Cash Flows (Tables)
75: R58 Summary of significant accounting and reporting HTML 84K
policies (Details)
76: R59 Summary of significant accounting and reporting HTML 59K
policies - Equity Method Investments (Details)
77: R60 Acquisitions and dispositions (Details) HTML 105K
78: R61 Securities - Amortized Cost, Gross Unrealized HTML 152K
Gains and Losses and Fair Value of Securities
(Detail)
79: R62 Securities - Securities Transferred From AFS to HTML 51K
HTM (Details)
80: R63 Securities - Net Securities Gains (Losses) HTML 56K
(Detail)
81: R64 Securities - Aggregate Fair Value of Investments HTML 171K
with Continuous Unrealized Loss Position (Detail)
82: R65 Securities - Maturity Distribution by Carrying HTML 161K
Amount and Yield (on Tax Equivalent Basis) of
Investment Securities Portfolio (Detail)
83: R66 Securities - Projected Weighted-Average Default HTML 59K
Rates and Loss Severities (Detail)
84: R67 Securities - Pre-Tax Net Securities Gains (Losses) HTML 62K
by Type (Detail)
85: R68 Securities - Debt Securities Credit Losses Roll HTML 59K
Forward Recorded in Earnings (Detail)
86: R69 Securities - Pledged assets (Details) HTML 73K
87: R70 Loans and asset quality - Details of Loan HTML 96K
Distribution and Industry Concentrations of Credit
Risk (Detail)
88: R71 Loans and asset quality - Allowance for Credit HTML 168K
Losses Activity (Details)
89: R72 Loans and asset quality - Nonperforming Assets HTML 66K
(Detail)
90: R73 Loans and asset quality - Lost Interest (Detail) HTML 55K
91: R74 Loans and asset quality - Information about HTML 111K
Impaired Loans (Detail)
92: R75 Loans and asset quality - Information about Past HTML 82K
Due Loans (Detail)
93: R76 Loans and asset quality- Troubled Debt HTML 62K
Restructurings (Detail)
94: R77 Loans and asset quality - Credit Quality HTML 75K
Indicators - Wealth Management Loans and Mortgages
- Credit Risk Profile by Internally Assigned Grade
(Detail)
95: R78 Loans and asset quality - Additional Information HTML 115K
(Details)
96: R79 Goodwill and intangible assets - Goodwill by HTML 73K
Business Segment (Detail)
97: R80 Goodwill and intangible assets - Intangible Assets HTML 71K
by Business Segment (Detail)
98: R81 Goodwill and intangible assets - Intangible Assets HTML 83K
by Type (Detail)
99: R82 Goodwill and intangible assets - Estimated Annual HTML 59K
Amortization Expense (Detail)
100: R83 Other assets (Detail) HTML 87K
101: R84 Other assets - Seed Capital and Private Equity HTML 67K
Investments Valued Using Net Asset Value (Detail)
102: R85 Other assets - Qualified Affordable Housing HTML 69K
Project Investments (Details)
103: R86 Deposits - Additional Information (Detail) HTML 65K
104: R87 Net interest revenue (Details) HTML 103K
105: R88 Noninterest Expense (Detail) HTML 85K
106: R89 Income Taxes - Narrative (Detail) HTML 74K
107: R90 Income Taxes - Provision (Benefit) for Income HTML 79K
Taxes from Continuing Operations (Detail)
108: R91 Income Taxes - Components of Income (Loss) before HTML 54K
Taxes (Detail)
109: R92 Income Taxes - Components of Net Deferred Tax HTML 80K
Liability (Detail)
110: R93 Income Taxes - Reconciliation of Statutory Federal HTML 77K
Income Tax Rate to Effective Income Tax Rate
(Detail)
111: R94 Income Taxes - Unrecognized Tax Positions (Detail) HTML 64K
112: R95 Long-Term Debt - Schedule of Long-term Debt HTML 70K
(Detail)
113: R96 Long-Term Debt - Summary of Trust Preferred HTML 67K
Securities Issued by Trusts (Detail)
114: R97 Long-Term Debt - Additional Information (Detail) HTML 68K
115: R98 Securitizations and variable interest entities - HTML 85K
Incremental Assets and Liabilities of Variable
Interest Entities Included in Consolidated
Financial Statements (Detail)
116: R99 Securitizations and variable interest entities - HTML 59K
Non-consolidated Variable Interest Entities
(Detail)
117: R100 Shareholders' equity - Narrative (Details) HTML 112K
118: R101 Shareholders' equity - Summary (Details) HTML 92K
119: R102 Shareholders' equity - Capital adequacy (Details) HTML 150K
120: R103 Other comprehensive income (loss) - Components HTML 117K
(Details)
121: R104 Other comprehensive income (loss) Other HTML 78K
Comprehensive Income (Loss) - Changes in
Accumulated Other Comprehensive Income (Loss)
(Details)
122: R105 Stock-based compensation - Additional Information HTML 109K
(Detail)
123: R106 Stock-based compensation - Summary of Stock Option HTML 91K
Activity (Detail)
124: R107 Stock-based compensation - Stock Options HTML 83K
Outstanding (Detail)
125: R108 Stock-based compensation - Aggregate Intrinsic HTML 53K
Value of Options (Detail)
126: R109 Stock-based compensation - Nonvested Restricted HTML 73K
Stock and Restricted Stock Units Activity (Detail)
127: R110 Employee Benefit Plans - Combined Data for HTML 157K
Domestic and Foreign Defined Benefit Pension and
Post Retirement Healthcare Plans (Detail)
128: R111 Employee Benefit Plans - Net Periodic Benefit HTML 111K
(Credit) Cost (Details)
129: R112 Employee Benefit Plans - Changes in Other HTML 76K
Comprehensive Income (Loss) (Details)
130: R113 Employee Benefit Plans - Amounts Expected to be HTML 61K
Recognized in Net Periodic Benefit Income (Cost)
(Details)
131: R114 Employee Benefit Plans - Defined Benefit Plan HTML 64K
Funded Status of Plan (Details)
132: R115 Employee Benefit Plans - Plans with Obligations in HTML 61K
Excess of Plan Assets (Details)
133: R116 Employee Benefit Plans - Benefit Payments for BNY HTML 77K
Mellons Pension and Healthcare Plans Expected to
be Paid (Details)
134: R117 Employee Benefit Plans - Pension Investment Asset HTML 75K
Allocation (Detail)
135: R118 Employee Benefit Plans - Pension Plan Investment HTML 171K
Assets Measured at Fair Value on Recurring Basis
(Detail)
136: R119 Employee Benefit Plans - Rollforward of Plan HTML 67K
Investment Assets Including Change in Fair Value
Classified in Level 3 of Valuation Hierarchy
(Detail)
137: R120 Employee Benefit Plans - Pension Plan Assets HTML 78K
Valued Using Net Asset Value (Detail)
138: R121 Employee Benefit Plans - Additional Information HTML 127K
(Detail)
139: R122 Company Financial Information Condensed Income HTML 92K
Statement Parent Corporation (Details)
140: R123 Company Financial Information Condensed Balance HTML 95K
Sheet Parent Corporation (Details)
141: R124 Company Financial Information Condensed Statement HTML 131K
of Cash Flows Parent Corporation (Details)
142: R125 Company Financial Information - Additional HTML 87K
Information (Details)
143: R126 Fair value measurement - Assets and Liabilities HTML 285K
Measured at Fair Value on Recurring Basis
(Details)
144: R127 Fair value measurement - Details of Certain Items HTML 213K
Measured at Fair Value on Recurring Basis
(Details)
145: R128 Fair value measurement - Significant Unobservable HTML 107K
Inputs (Details)
146: R129 Fair value measurement - Assets Measured at Fair HTML 67K
Value on Nonrecurring Basis (Details)
147: R130 Fair value measurement - Carrying Amount and Fair HTML 100K
Value of Financial Instruments (Details)
148: R131 Fair value measurement - Summary of Carrying HTML 59K
Amount of Hedged Financial Instruments, Related
Notional Amount of Hedge and Estimated Fair Value
of Derivatives (Details)
149: R132 Fair Value Measurement - Additional Information HTML 52K
(Details)
150: R133 Fair value option - Assets and Liabilities, by HTML 64K
Type, of Consolidated Investment Management Funds
Recorded at Fair Value (Detail)
151: R134 Fair value option - Changes in Fair Value of the HTML 56K
Loans and Long-Term Debt and the Location of the
Changes (Details)
152: R135 Fair value option - Narrative (Details) HTML 57K
153: R136 Commitments and contingent liabilities - HTML 88K
Significant Industry Concentrations Related to
Credit Exposure (Details)
154: R137 Commitments and contingent liabilities - Summary HTML 62K
of Off-Balance Sheet Credit Risks, Net of
Participations (Details)
155: R138 Commitments and contingent liabilities - Standby HTML 56K
Letters of Credits by Investment Grade (Details)
156: R139 Commitments and contingent liabilities - Narrative HTML 124K
(Details)
157: R140 Derivative instruments - Narrative (Details) HTML 95K
158: R141 Derivative instruments - Ineffectiveness Related HTML 60K
to Derivatives and Hedging Relationships Recorded
in Income (Details)
159: R142 Derivative instruments - Impact of Derivative HTML 99K
Instruments on Balance Sheet (Details)
160: R143 Derivative instruments - Impact of Derivative HTML 92K
Instruments on Income Statement (Details)
161: R144 Derivative instruments - Revenue from Foreign HTML 57K
Exchange and Other Trading (Details)
162: R145 Derivative instruments - Fair Value of Derivative HTML 59K
Contracts Falling under Early Termination
Provisions in Net Liability Position (Details)
163: R146 Derivative instruments - Offsetting (Details) HTML 239K
164: R147 Derivative instruments - Secured Borrowings HTML 106K
(Details)
165: R148 Lines of business - Narrative (Details) HTML 56K
166: R149 Lines of business - Contribution of Segments to HTML 97K
Overall Profitability (Details)
167: R150 International Operations - Foreign Revenue, Income HTML 73K
before Income Taxes, Net Income and Assets from
Foreign Operations (Detail)
168: R151 International Operations (Details) HTML 58K
169: R152 Supplemental information to the Consolidated HTML 68K
Statement of Cash Flows- Noncash Investing and
Financing Transactions that are Not Reflected in
Consolidated Statement of Cash Flows (Detail)
171: XML IDEA XML File -- Filing Summary XML 326K
170: EXCEL IDEA Workbook of Financial Reports XLSX 284K
12: EX-101.INS XBRL Instance -- bk-20161231 XML 16.76M
14: EX-101.CAL XBRL Calculations -- bk-20161231_cal XML 709K
15: EX-101.DEF XBRL Definitions -- bk-20161231_def XML 2.37M
16: EX-101.LAB XBRL Labels -- bk-20161231_lab XML 4.91M
17: EX-101.PRE XBRL Presentations -- bk-20161231_pre XML 3.19M
13: EX-101.SCH XBRL Schema -- bk-20161231 XSD 523K
172: ZIP XBRL Zipped Folder -- 0001390777-17-000065-xbrl Zip 972K
| Exhibit |
1. | I have reviewed this annual report on Form 10-K of The Bank of New York Mellon Corporation (the “registrant”); |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Name: Gerald L. Hassell | |
Title: Chief Executive Officer | |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/28/17 | 4 | ||
| For Period end: | 12/31/16 | 11-K, 13F-HR, 5, 8-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/08/21 Bank of New York Mellon Corp. 424B2 1:761K Donnelley … Solutions/FA |